Join Sara E. Wakeman, MD as she presents Innovation in Opiod Disorder Treatment. Learning objectives: Understand the epidemiology of the opioid overdose crisis Describe effective treatments for opioid use disorder Detail innovative approaches to starting medications for opioid use disorder
Innovation in Opioid Use Disorder Treatment Read More »
Please join Alane O’Connor, DNP and Kara Kaikini, MS, IBCLC, as they discuss the Guidelines for the Use of Human Milk in the Context of Substance Use Disorder Description: Breastfeeding initiation rates are significantly lower in pregnant women with substance use disorder (SUD). While prenatal intention to breastfeed is often high in women receiving SUD
Guidelines for the Use of Human Milk in the Context of Substance Use Disorder Read More »
Please join Erik Lamoreau, LADC, CCS, as he discusses creating a recovery center in rural communities. Learning Objectives: How to leverage support in the community? Functionality of the center and volunteers. Creating long-term sustainability of the center. Moving Beyond recovery center to other community-based recovery resources.
Creating a Recovery Center in Rural Communities Read More »
Please join Nicolette Centanni, PharmD, BCPS, BCGP, BCPP, as she explores overdose reversal medications in this PMP Series. Learning Objectives: 1. Identify what overdose reversal medications are currently available 2. Describe how overdose reversal medications counteract the effects of opioids in the body 3. Discuss differences and similarities in overdose reversal medications and common scenarios
PMP Series | Overdose Reversal Medications Read More »
Please join Nicolette Centanni, PharmD, BCPS, BCGP, BCPP, who will discuss Methadone Safety and Current Dosing in Opioid Use Disorder. Learning Objectives: Review a brief history of methadone for OUD in the United States Discuss the mechanism of action and safety of methadone Evaluate current literature pertaining to rapid methadone titration
Methadone Safety and Current Dosing in Opioid Use Disorder Read More »
In this presentation Robert Lawlor Jr. MS-ADPP, MS, BSCJ provides an overview of the current illicit drug environment, with a focus on emerging trends, common adulterants, and the growing risks they create for both public health and public safety. Participants will gain a clearer understanding of how today’s drug supply is changing and why awareness
The Modern Illicit Drug Environment, Adulterants, Trends, and Threats Read More »
Join Courtney Pladsen, DNP, FNP, RN, and Kate Russell Woodworth, MD, MPH, FAAP, as they explore the intersection of infectious disease and substance use in Maine and discuss strategies to improve screening, prevention, and care. Learning Objectives: Recognize current infectious disease trends and common co-infections (HIV, HCV, HBV, STIs) among patients with substance use disorder
Infectious Disease Syndemic and Substance Use in Maine: From Surveillance to Action Read More »
This interactive lecture invites healthcare professionals to explore how stigma shows up in clinical language, policies, and unconscious bias—and how trauma-informed care and battling compassion fatigue can transform patient experiences. Participants will learn practical tools to increase patients’ sense of safety, choice, collaboration, and empowerment across care settings. Learning Objectives: Analyze how stigma manifests in
This presentation reviews the logistics of initiating Extended-Release Buprenorphine (XRB) services in your office while maintaining regulatory compliance. We will explore the different procurement pathways and how each option impacts both practice budgets and patient out-of-pocket costs. Additionally, we will examine available financial assistance resources and strategies to help provide XRB at little to no
This talk will review the symptoms and behaviors often termed behavioral and psychological symptoms of dementia (BPSD). Literature that lead to national guidelines will be evaluated and explained for a better understanding of the pathophysiology and treatment of these often distressing symptoms. The place in therapy of antipsychotics and other medical and non-medical interventions in
Behavioral and Psychological Symptoms of Dementia Read More »
